Search Count: 11
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2014-12-24 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2Q8 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2014-12-24
Ligands: 2Q8
 |
Influenza Polymerase Basic Protein 2 (Pb2) Bound To 7-Methyl-Gtp
Organism: Influenza a virus
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2014-07-30 Classification: TRANSCRIPTION/TRANSCRIPTION INHIBITOR Ligands: MGT, 11H |
Organism: Influenza a virus
Method: X-RAY DIFFRACTION
Release Date: 2014-07-30
Ligands: MGT, 11H
 |
Influenza Polymerase Basic Protein 2 (Pb2) Bound To A Small-Molecule Inhibitor
Organism: Influenza a virus
Method: X-RAY DIFFRACTION Resolution:2.82 Å Release Date: 2014-07-30 Classification: TRANSCRIPTION/TRANSCRIPTION INHIBITOR Ligands: 704 |
Organism: Influenza a virus
Method: X-RAY DIFFRACTION
Release Date: 2014-07-30
Ligands: 704
 |
Influenza A (Flu) Virus Polymerase Basic Protein 2 (Pb2) Bound To Vx787, An Azaindole Inhibitor
Organism: Influenza a virus
Method: X-RAY DIFFRACTION Resolution:2.52 Å Release Date: 2014-07-30 Classification: transferase/transferase inhibitor Ligands: 21G |
Organism: Influenza a virus
Method: X-RAY DIFFRACTION
Release Date: 2014-07-30
Ligands: 21G
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2Q9 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2014-04-09
Ligands: 2Q9
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: FGH |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2014-04-09
Ligands: FGH
 |
Identification Of Novel Hsp90 / Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2R6 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2014-04-09
Ligands: 2R6
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2QA |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2014-04-09
Ligands: 2QA
 |
Crystal Structure Of Complex Between Amino And Carboxy Terminal Fragments Of Mdia1
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:3.20 Å Release Date: 2010-10-13 Classification: PROTEIN BINDING |
Organism: Mus musculus
Method: X-RAY DIFFRACTION
Release Date: 2010-10-13
 |
Crystal Structure Of The Autoinhibitory Switch In Formin Mdia1; The Did/Dad Complex
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2006-05-30 Classification: STRUCTURAL PROTEIN |
Organism: Mus musculus
Method: X-RAY DIFFRACTION
Release Date: 2006-05-30
 |
Crystal Structure Of Plasmepsin Ii, An Aspartyl Protease From Plasmodium Falciparum, In Complex With A Statine-Based Inhibitor
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2004-01-20 Classification: HYDROLASE Ligands: IVS |
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION
Release Date: 2004-01-20
Ligands: IVS